Dendritic cell-based Immunotherapy in patients with primary glioblastoma multiforme -Phase I/IIa clinical trial.

Trial Profile

Dendritic cell-based Immunotherapy in patients with primary glioblastoma multiforme -Phase I/IIa clinical trial.

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Cancer vaccine (Primary)
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 17 Sep 2015 Changed linked RDI profile from 36305 to 26658
    • 28 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by Korean Clinical Trials Register.
    • 09 May 2012 Status changed from not yet recruiting to recruiting as reported by Korean Clinical Trials Register
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top